Apple Vision Pro is seeing returns, possibly due to high price and lack of apps. US drug prices rising. Open AI launches text-to-video model. The hosts discuss the drawbacks of Apple Vision Pro and speculate on Apple's next priority. They compare Apple's moment to Meta and Mark Zuckerberg's success as CEO.
14:57
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
The Apple Vision Pro has received significant returns due to discomfort and lack of essential features, possibly influenced by its high price tag.
US drug prices have increased by 4.7% in January, raising concerns about the affordability of essential medications.
Deep dives
Mixed reviews and returns for Apple Vision Pro
The Apple Vision Pro, released on February 2nd, has garnered mixed reviews and a significant number of returns. Some users have complained about the device being uncomfortable, causing headaches, and lacking essential features. The high price tag of $3,500 and the limited number of game-changing apps have also been cited as reasons for dissatisfaction. Competitors like Mark Zuckerberg's Quest 3 have highlighted their own advantages, such as being lighter, wireless, and more affordable. While Apple generated significant buzz with the Vision Pro, it remains to be seen whether the product will be a success or a failure.
Target's new budget-conscious brand
Target has introduced a new brand with approximately 400 products, priced below $10, to attract budget-conscious shoppers and compete with dollar stores. This new brand will replace Target's own smartly brand. The move comes as Target aims to cater to price-sensitive consumers and offer more affordable options for everyday essentials.
US drug prices increase in January
In January, US drug prices saw a median increase of 4.7% across about 900 medications, including diabetes medications like Ozempic and Mungenro. This spike in prices, combined with recent overall inflation, has raised concerns about the affordability of essential medications, particularly for individuals without insurance coverage. With drug prices being a prominent election-year issue, there is a growing demand for solutions to mitigate the impact of rising healthcare costs on patients.
Headaches, eye strain and discomfort are just some of the reasons Apple Vision Pro is seeing quite a few returns since its launch. Was the $3.5k price point too much for this product, or are the lack of apps to blame? Plus: US drug prices are on the rise and Open AI launches a text-to-video model.
Join our hosts Jon Weigell and Ben Berkley, as they take you through our most interesting stories of the day.
Thank You For Listening to The Hustle Daily Show. Don’t forget to hit Subscribe or Follow us on Apple Podcasts so you never miss an episode! If you want this news delivered to your inbox, join millions of others and sign up for The Hustle Daily newsletter, here: https://thehustle.co/email/